New drug for stiff person syndrome granted fast-track designation from FDA
the patient Hard-headed person syndrome We are one step closer to accessing new treatments. Kiberna Therapeutics announced on Monday that its new drug, KYV-101, has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the U.S. Food and Drug Administration (FDA). Drugs eligible for RMAT designation are those “intended to treat, ameliorate, ameliorate, or cure […]
Is FDA experimenting on postpartum mothers doctor says YES
After giving birth, all new mothers are screened, usually multiple times, for postpartum depression, which research shows is the most common complication of childbirth. If a woman is determined to be suffering from postpartum depression, she is often prescribed selective serotonin reuptake inhibitors, which are commonly used to treat depression. But how effective are these […]